HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line.

Abstract
Histamine is produced by many cells expressing histidine decarboxylase (HDC), the enzyme responsible for the synthesis of histamine. Since melanoma cells and tissue contain relatively large amounts of histamine, the functional significance of histamine was examined using specific antihistamines in vitro and in vivo in the human melanoma cell line HT168 and severe combined immunodeficiency (SCID) mice. It was shown that the H2 receptor antagonist cimetidine when combined with N, N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HCl (DPPE), a tamoxifen derivate, inhibits the proliferation of HT168 cells. Furthermore, it is suggested that there is a factor(s) that interferes with the exponential growth of HT168 cells xenografted to immunodeficient mice, and cimetidine and DPPE together significantly influence this factor(s). This combination of antihistamines also increases the survival of human melanoma-grafted mice. These changes are accompanied by enhanced infiltration of interferon-gamma- producing mouse macrophages into the tumour tissue. These findings suggest that two different mechanisms are probably acting concordantly: direct inhibition of tumour cell proliferation by the H2 receptor antagonists, and activation of the local immune response characterized by interferon-gamma production. These findings may help to elucidate the possibility of a rationally designed antihistamine strategy in melanoma therapy.
AuthorsN Szincsák, H Hegyesi, J Hunyadi, G Martin, E Lázár-Molnár, P Kovács, E Rivera, A Falus, I Juhász
JournalMelanoma research (Melanoma Res) Vol. 12 Issue 3 Pg. 231-40 (Jun 2002) ISSN: 0960-8931 [Print] England
PMID12140379 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Histamine H2 Antagonists
  • Neoplasm Proteins
  • Phenyl Ethers
  • RNA, Messenger
  • RNA, Neoplasm
  • Receptors, Histamine H2
  • Cimetidine
  • Interferon-gamma
  • Cytochrome P-450 Enzyme System
  • Histidine Decarboxylase
  • tesmilifene
Topics
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Autocrine Communication (drug effects)
  • Cell Division (drug effects)
  • Cimetidine (administration & dosage)
  • Cytochrome P-450 Enzyme System (metabolism)
  • Drug Synergism
  • Histamine H2 Antagonists (administration & dosage)
  • Histidine Decarboxylase (metabolism)
  • Humans
  • Interferon-gamma (metabolism)
  • Macrophages (metabolism, pathology)
  • Melanoma (enzymology, pathology)
  • Melanoma, Experimental (drug therapy, enzymology, prevention & control)
  • Mice
  • Mice, SCID
  • Neoplasm Proteins (metabolism)
  • Phenyl Ethers (administration & dosage)
  • RNA, Messenger (analysis)
  • RNA, Neoplasm (analysis)
  • Receptors, Histamine H2 (genetics, metabolism)
  • Tumor Cells, Cultured (transplantation)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: